Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Free Sterols/Stanols Efficacious For CHD Risk Reduction - Novartis

This article was originally published in The Tan Sheet

Executive Summary

Free sterols and stanols should be considered the active phytosterol substances in cholesterol-reducing foods and supplements carrying FDA's recently approved health claims, Novartis and Forbes Medi-Tech argue in Nov. 21 comments to the agency.

You may also be interested in...



Sterol/Stanol Warning For Children, Pregnant Women Unsupported – Altus

Existing safety data do not justify restricting the phytosterol intake of infants, children or pregnant/ lactating women, Altus Food Company tells FDA

Sterol/Stanol Warning For Children, Pregnant Women Unsupported – Altus

Existing safety data do not justify restricting the phytosterol intake of infants, children or pregnant/ lactating women, Altus Food Company tells FDA

Sterol/Stanol Warning For Children, Pregnant Women Unsupported – Altus

Existing safety data do not justify restricting the phytosterol intake of infants, children or pregnant/ lactating women, Altus Food Company tells FDA

Related Content

Topics

UsernamePublicRestriction

Register

PS091983

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel